Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3701 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3701-3701

Author(s):

G. Lopez-Vivanco ◽

A. Muñoz ◽

J. M. Mañe ◽

J. Ferreiro ◽

I. Rubio ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Line Treatment ◽

Second Line ◽

Metastatic Colorectal Carcinoma

Download Full-text

A Randomised Phase II Study of Irinotecan in Combination with 5-FU/FA Compared with Irinotecan Alone as Second-Line Treatment of Patients with Metastatic Colorectal Carcinoma

Oncology Research and Treatment ◽

10.1159/000099636 ◽

2007 ◽

Vol 30 (4) ◽

pp. 169-174 ◽

Author(s):

Ullrich Graeven ◽

Dirk Arnold ◽

Anke Reinacher-Schick ◽

Theodor Heuer ◽

Arnd Nusch ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Second Line ◽

Metastatic Colorectal Carcinoma

Download Full-text

Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3701 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3701-3701

Author(s):

G. Lopez-Vivanco ◽

A. Muñoz ◽

J. M. Mañe ◽

J. Ferreiro ◽

I. Rubio ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Line Treatment ◽

Second Line ◽

Metastatic Colorectal Carcinoma

Download Full-text

2118 Quality of life (QoL) during second-line treatment with FOLFIRI +/- panitumumab (pmab) in patients (pts) with RAS wild-type (WT) metastatic colorectal carcinoma (mCRC)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31040-1 ◽

2015 ◽

Vol 51 ◽

pp. S369-S370

Author(s):

A.F. Sobrero ◽

T.J. Price ◽

A. Cervantes ◽

M. Ducreux ◽

T. Andre ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Carcinoma ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

Metastatic Colorectal Carcinoma

Download Full-text

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

JMIR Research Protocols ◽

10.2196/11545 ◽

2019 ◽

Vol 8 (1) ◽

pp. e11545 ◽

Author(s):

Nikhil Chauhan ◽

Mary F Mulcahy ◽

Riad Salem ◽

Al B Benson III ◽

Eveline Boucher ◽

...

Keyword(s):

Clinical Trial ◽

Colorectal Carcinoma ◽

Randomized Clinical Trial ◽

Line Treatment ◽

Second Line ◽

Metastatic Colorectal Carcinoma ◽

Glass Microspheres ◽

Phase 3 ◽

Download Full-text

Phase II Clinical Trial for Prevention of Delayed Diarrhea with Cholestyramine/Levofloxacin in the Second-Line Treatment with Irinotecan Biweekly in Patients with Metastatic Colorectal Carcinoma

Oncology ◽

10.1159/000111083 ◽

2007 ◽

Vol 72 (1-2) ◽

pp. 10-16 ◽

Author(s):

Dimitri Flieger ◽

Christine Klassert ◽

Sabine Hainke ◽

Ralf Keller ◽

Rolf Kleinschmidt ◽

...

Keyword(s):

Clinical Trial ◽

Colorectal Carcinoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

Second Line ◽

Metastatic Colorectal Carcinoma

Download Full-text

Faculty Opinions recommendation of Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727549021.793550895 ◽

2018 ◽

Author(s):

Sebastian Stintzing

Keyword(s):

Overall Survival ◽

Colorectal Carcinoma ◽

Final Analysis ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

First Line Treatment

Download Full-text

Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.03.007 ◽

2017 ◽

Vol 78 ◽

pp. 61-69 ◽

Author(s):

Takayuki Yoshino ◽

Radka Obermannová ◽

György Bodoky ◽

Rocio Garcia-Carbonero ◽

Tudor Ciuleanu ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Carcinoembryonic Antigen ◽

Predictive Factor ◽

Phase Iii ◽

Second Line ◽

Metastatic Colorectal Carcinoma ◽

Phase Iii Trial

Download Full-text

The Cost Study of First- line Treatment of Metastatic Colorectal Carcinoma with Bevacizumab- containing Regimen in the Czech Republic

Klinicka onkologie ◽

10.14735/amko2014255 ◽

2014 ◽

Vol 27 (4) ◽

pp. 255-260

Author(s):

Irena Hradecká ◽

Barbora Říhová ◽

Renata Horová ◽

Regina Demlová

Keyword(s):

Czech Republic ◽

Colorectal Carcinoma ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

The Czech Republic ◽

The Cost ◽

First Line Treatment

Download Full-text

Second line chemotherapy for metastatic colorectal carcinoma

Oncology Reports ◽

10.3892/or.3.5.867 ◽

1996 ◽

Author(s):

V Gebbia ◽

A Testa ◽

G Cannata ◽

M Tirrito ◽

A Longo ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Second Line ◽

Metastatic Colorectal Carcinoma ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Download Full-text

Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2019.08.003 ◽

2020 ◽

Vol 19 (1) ◽

pp. 39-47.e5 ◽

Author(s):

Marie Auvray ◽

David Tougeron ◽

Edouard Auclin ◽

Valérie Moulin ◽

Pascal Artru ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Multicenter Study ◽

Second Line ◽

Efficacy And Safety ◽

Metastatic Colorectal Carcinoma ◽

Second Line Therapy ◽

Download Full-text